No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs182251844 |
chr12:9564671-9564672 |
Weak transcription Strong transcription Enhancers Flanking Active TSS
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
2 |
rs113021273 |
chr12:9564704-9564705 |
Weak transcription Strong transcription Enhancers Flanking Active TSS
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs74062840 |
chr12:9564705-9564706 |
Weak transcription Strong transcription Enhancers Flanking Active TSS
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
4 |
rs10843720 |
chr12:9564727-9564728 |
Weak transcription Strong transcription Enhancers Flanking Active TSS
|
lncRNA
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
5 |
rs186150681 |
chr12:9564737-9564738 |
Weak transcription Strong transcription Enhancers Flanking Active TSS
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
6 |
rs145662627 |
chr12:9564749-9564750 |
Weak transcription Strong transcription Enhancers Flanking Active TSS
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
7 |
rs569736061 |
chr12:9564768-9564769 |
Weak transcription Strong transcription Enhancers Flanking Active TSS
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs181482566 |
chr12:9564778-9564779 |
Weak transcription Strong transcription Enhancers Flanking Active TSS
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs191005698 |
chr12:9564795-9564796 |
Weak transcription Strong transcription Enhancers Flanking Active TSS
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs74062841 |
chr12:9564826-9564827 |
Weak transcription Strong transcription Enhancers
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs74062842 |
chr12:9564861-9564862 |
Weak transcription Strong transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
12 |
rs182834714 |
chr12:9564908-9564909 |
Weak transcription Strong transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs544525619 |
chr12:9564937-9564938 |
Weak transcription Strong transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs368408011 |
chr12:9565044-9565045 |
Weak transcription Strong transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs555465081 |
chr12:9565158-9565159 |
Weak transcription Strong transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs147353598 |
chr12:9565205-9565206 |
Weak transcription Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs386760181 |
chr12:9565206-9565207 |
Weak transcription Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs12296667 |
chr12:9565208-9565209 |
Weak transcription Flanking Active TSS Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
19 |
rs150582255 |
chr12:9565257-9565258 |
Weak transcription Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs188540284 |
chr12:9565293-9565294 |
Weak transcription Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs370589452 |
chr12:9565303-9565304 |
Weak transcription Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs117707113 |
chr12:9565400-9565401 |
Weak transcription Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs192912045 |
chr12:9565404-9565405 |
Weak transcription Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs111352058 |
chr12:9565534-9565535 |
Weak transcription Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs201355602 |
chr12:9565552-9565553 |
Weak transcription Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs182796829 |
chr12:9565555-9565556 |
Weak transcription Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs145202058 |
chr12:9565636-9565637 |
Weak transcription Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
28 |
rs116470785 |
chr12:9565642-9565643 |
Weak transcription Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs188307454 |
chr12:9565680-9565681 |
Weak transcription Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
30 |
rs568492967 |
chr12:9565732-9565733 |
Weak transcription Flanking Active TSS Enhancers
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs55638494 |
chr12:9565753-9565754 |
Weak transcription Flanking Active TSS Enhancers
|
lncRNA
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
32 |
rs557564451 |
chr12:9565756-9565757 |
Weak transcription Flanking Active TSS Enhancers
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs191300056 |
chr12:9565817-9565818 |
Weak transcription Flanking Active TSS Enhancers
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs148385680 |
chr12:9565823-9565824 |
Weak transcription Flanking Active TSS Enhancers
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs183888066 |
chr12:9565837-9565838 |
Weak transcription Flanking Active TSS Enhancers
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs189398648 |
chr12:9565900-9565901 |
Weak transcription Flanking Active TSS Enhancers
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
37 |
rs537072521 |
chr12:9565920-9565921 |
Weak transcription Flanking Active TSS Enhancers
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs7312968 |
chr12:9565979-9565980 |
Weak transcription Flanking Active TSS Enhancers
|
lncRNA
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
39 |
rs543214492 |
chr12:9566122-9566123 |
Weak transcription Active TSS Enhancers
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs59453560 |
chr12:9566138-9566139 |
Weak transcription Active TSS Enhancers
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs56091587 |
chr12:9566200-9566201 |
Weak transcription Active TSS Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
42 |
rs56878978 |
chr12:9566247-9566248 |
Weak transcription Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
43 |
rs192635799 |
chr12:9566254-9566255 |
Weak transcription Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
44 |
rs10843723 |
chr12:9566302-9566303 |
Weak transcription Active TSS Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
45 |
rs71447570 |
chr12:9566340-9566341 |
Weak transcription Active TSS Enhancers
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
46 |
rs549823872 |
chr12:9566371-9566372 |
Weak transcription Active TSS Enhancers
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
47 |
rs569906932 |
chr12:9566412-9566413 |
Weak transcription Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
48 |
rs7967859 |
chr12:9566465-9566466 |
Weak transcription Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
49 |
rs150736580 |
chr12:9566521-9566522 |
Weak transcription Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
50 |
rs548730490 |
chr12:9566531-9566532 |
Weak transcription Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|